Cargando…
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
Currently, resistance to trastuzumab, a human epidermal growth factor receptor 2 (HER2) inhibitor, has become an important obstacle to improving the clinical outcome of patients with advanced HER2(+) breast cancer. While cell behavior may be modulated by long non-coding RNAs (lncRNAs), the contribut...
Autores principales: | Dong, Huaying, Wang, Wei, Chen, Ru, Zhang, Yu, Zou, Kejian, Ye, Mulin, He, Xionghui, Zhang, Fan, Han, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065402/ https://www.ncbi.nlm.nih.gov/pubmed/30015837 http://dx.doi.org/10.3892/ijo.2018.4467 |
Ejemplares similares
-
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022) -
Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation
por: Dong, Huaying, et al.
Publicado: (2018) -
Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2019) -
Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2021) -
Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2022)